about
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findingsThe peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseasesRole of non-neuronal cells in body weight and appetite controlTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseRole of Nuclear Receptors in Central Nervous System Development and Associated DiseasesBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseBezafibrate administration improves behavioral deficits and tau pathology in P301S miceFenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive propertiesRole of platelets in neuroinflammation: a wide-angle perspectivePalmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-αCyanide-induced death of dopaminergic cells is mediated by uncoupling protein-2 up-regulation and reduced Bcl-2 expressionEffects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemiaEffects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in miceModulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma.Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE).In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityPast, present and future therapeutics for cerebellar ataxias.Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.Activation of PPARalpha Attenuates IFNgamma and IL-1beta-induced Cell Proliferation in Astrocytes: Involvement of IL-6 Independent Pathway.PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma statusHyperforin promotes mitochondrial function and development of oligodendrocytes.Assessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis.PPAR agonists regulate brain gene expression: relationship to their effects on ethanol consumptionPalmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-αEffects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice.Effects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain.Nuclear receptors as therapeutic targets for Alzheimer's diseasePan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficitsPro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study.Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesTranscriptomic analysis unveils correlations between regulative apoptotic caspases and genes of cholesterol homeostasis in human brain.Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosisConsequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseasePioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α.BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's diseaseThe synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.
P2860
Q21090748-8D6F5265-08EC-4A0A-82DB-CB8345209489Q24612698-7E562F28-C465-4757-A437-636C6921F8BAQ26828875-C2CA61D2-5F08-4181-9932-1570027D1E1AQ27021700-54834324-FCF4-4C66-8FAE-7DFF436C85B8Q27025212-D5C93A08-D2DC-4101-A44F-C97ECFB05817Q28259585-020D3DCC-F71B-4C4D-A528-DC0AA6432F97Q28273620-54FBD8AA-ABC1-43F6-9712-DB8838B7560FQ28302788-384F72ED-CB43-4C4E-9A06-685371AA845DQ28393808-A68779F0-03A5-423B-8C23-9FA545440CEEQ28568120-9797E223-5718-4A16-BB4A-AD4CDB3BB099Q28583248-EA844AA9-BB98-40DE-B974-D736CDF9028AQ30490910-C2C91E22-59AB-4B46-BCE6-55A8206435DAQ30573773-65719407-C37C-4592-BA6E-6D17AEFAFDBBQ33442332-C43F6726-F9E6-4247-919C-BA9E4F2C868FQ33575523-AFCEECF3-CA8E-485F-9B07-4B7870F73FEBQ33728403-D68E3E89-C216-4E6C-AD74-47387100C729Q33751118-EED09A15-66A6-4637-8689-54063DC4749EQ33836935-A389C19E-4929-42BF-B4B2-791F3069885BQ33959032-AD7C0B29-2482-4E40-AC97-64B2E8938471Q33988371-A2920EF1-33E0-480F-B89B-3947FE8C6F52Q34203838-7132C810-A03D-4B4B-AD9B-140927CFCD6FQ34208604-7E62F0E5-C9FF-469B-AA43-7823CCF3F4A5Q34230420-533C3BC1-C5E7-408E-B7F8-8EA747292FF9Q34302561-60B31AD8-B803-4228-B83B-A9C141C31B6CQ34636570-24CDD2A9-CF4A-4C2E-8E53-2CEBB33CF6B0Q34970533-4786178C-60A9-4827-9571-7B9CF9F2420BQ35073600-2AEF03F9-2D7C-40DD-B506-AE95FA56711FQ35165186-71888814-BCF3-40F4-A12F-D81106F45363Q35176258-181D75E9-2C96-4D23-9FB1-E62FE714F372Q35203663-C3CD4D31-7BC8-403D-9E5C-658190847CF5Q35210023-5A742AB5-0A27-447B-8886-5C2888E64167Q35350853-407A83BC-C071-4EAF-B87E-9A973CEF3FAFQ35643703-61886994-8B74-4240-A57E-04793DDD4FD3Q35687048-061366C3-C2A0-4627-8768-3B6BE2378E69Q35832686-8F52C3A7-895D-47DC-9C9B-92F054076566Q35997824-3BF774F6-A91B-462C-A9C8-7FF38703A93DQ36100305-6AAF759B-1F82-44D5-A859-D79A0E254F66Q36127141-4A669E5F-F96A-4520-8B7E-7A5283D864E6Q36427048-DBFB2BD3-66BC-4FAE-A7C0-1B80FAF42411Q36676619-95BCF5EE-6F5D-4D4D-A3E5-A665B1CD5D28
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
PPARs in the brain.
@en
type
label
PPARs in the brain.
@en
prefLabel
PPARs in the brain.
@en
P1476
PPARs in the brain.
@en
P2093
Gary E Landreth
Michael T Heneka
P304
P356
10.1016/J.BBALIP.2007.04.016
P407
P577
2007-05-10T00:00:00Z